Pediatric, Adolescent, and Young Adult Section, Joslin Diabetes Center, Boston, Massachusetts, USA.
Division of Endocrinology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Diabetes Technol Ther. 2022 Dec;24(12):915-919. doi: 10.1089/dia.2022.0170. Epub 2022 Sep 5.
Emerging adults (EAs) with type 1 diabetes (T1D) often experience challenges in diabetes management, in particular transitioning to financial independence. EAs 18-30 years of age with T1D completed online surveys about diabetes distress and an open-ended query about the most important worry among survey questions. Most of the 287 respondents (89.5%) endorsed "Agree" or "Somewhat agree" to the statement "I worry about the cost of diabetes." Responses did not differ by gender, age, diabetes duration, race/ethnicity, diabetes technology use, student status, income, or insurance status. However, a greater proportion of those not endorsing cost as a substantial burden achieved A1c <7% (92.9%) versus those who were neutral (46.2%) or who endorsed cost as a burden (50.6%) ( = 0.004). Furthermore, in open-ended responses, cost was the most frequently noted worry. Diabetes costs are a major concern for EAs, likely contributing to diabetes distress during this developmental stage, and clinicians should consider discussing diabetes costs with this population.
患有 1 型糖尿病(T1D)的青年成年人(EAs)在糖尿病管理方面经常面临挑战,特别是在向财务独立过渡方面。287 名年龄在 18-30 岁的 T1D 青年成年人完成了关于糖尿病困扰的在线调查和关于调查问题中最重要担忧的开放式查询。大多数受访者(89.5%)对“我担心糖尿病的费用”这一说法表示“同意”或“有些同意”。性别、年龄、糖尿病持续时间、种族/民族、糖尿病技术使用、学生身份、收入或保险状况对回复没有影响。然而,不认为费用是一个很大负担的人中有更大比例的糖化血红蛋白(A1c)<7%(92.9%),而持中立态度的人(46.2%)或认为费用是负担的人(50.6%)(=0.004)。此外,在开放式回复中,费用是最常提到的担忧。糖尿病的费用是 EAs 的一个主要关注点,可能会在这个发展阶段导致糖尿病困扰,临床医生应该考虑与这一人群讨论糖尿病的费用。